{
  "slug": "saffron",
  "version": "1",
  "displayName": "Saffron (Crocus sativus) extract",
  "unit": "mg",
  "doseKind": "compound",
  "ingredientGroups": [
    "Saffron"
  ],
  "shelfComparable": true,
  "primaryFloorId": "aisd-men",
  "trialFloors": [
    {
      "id": "aisd-men",
      "label": "Fluoxetine-related sexual dysfunction, men",
      "presetLabel": "Men (AISD)",
      "amount": 30,
      "frequency": "daily",
      "horizon": "4 weeks",
      "evidenceLevel": "limited",
      "pmids": [
        "22552758"
      ],
      "n": 30,
      "note": "15 mg twice daily in men whose depression was already stabilised on fluoxetine. Erectile function and intercourse satisfaction improved; orgasmic function, overall satisfaction and desire did not. Thirty completers in a single Iranian centre.",
      "effectDirection": "benefit",
      "funding": "not-stated"
    },
    {
      "id": "aisd-women",
      "label": "Fluoxetine-related sexual dysfunction, women",
      "presetLabel": "Women (AISD)",
      "amount": 30,
      "frequency": "daily",
      "horizon": "4 weeks",
      "evidenceLevel": "limited",
      "palette": "feminine",
      "pmids": [
        "23280545"
      ],
      "n": 34,
      "note": "Same 30 mg/day in women stabilised on fluoxetine 40 mg. Total FSFI, arousal, lubrication and pain improved; desire did not. Separate trial, separate instrument — do not read the men's result into this one or the reverse.",
      "effectDirection": "benefit",
      "funding": "not-stated"
    },
    {
      "id": "postpartum-vs-fluoxetine",
      "label": "Postpartum depression, saffron vs fluoxetine",
      "presetLabel": "Postpartum",
      "amount": 30,
      "frequency": "daily",
      "horizon": "6 weeks",
      "evidenceLevel": "limited",
      "palette": "research",
      "pmids": [
        "27595298"
      ],
      "n": 64,
      "note": "15 mg twice daily against fluoxetine 20 mg twice daily in mild-to-moderate postpartum depression. There was no significant difference between arms, and complete response was 40.6% on saffron vs 50.0% on fluoxetine — an active-comparator trial with no placebo arm, so it does not establish that saffron beat nothing.",
      "effectDirection": "null",
      "funding": "not-stated"
    },
    {
      "id": "depression-meta",
      "label": "Depression meta-analyses (pooled)",
      "presetLabel": "Depression meta",
      "amount": 30,
      "frequency": "daily",
      "evidenceLevel": "limited",
      "palette": "research",
      "pmids": [
        "24299602",
        "31118846"
      ],
      "note": "Pooled saffron-vs-placebo effect was large but the confidence interval reached zero (SMD −0.86, 95% CI −1.73 to 0.00), and saffron did not differ from fluoxetine. Eight small trials, most from a single country. Treat 30 mg/day as the dose those trials used, not as a settled effective dose.",
      "effectDirection": "null",
      "funding": "industry",
      "funder": "Reserveage Organics"
    }
  ],
  "guideSlugs": [
    "supplements-for-ssri-induced-ed",
    "winter-blues-supplements"
  ],
  "guideUrls": [
    "https://supplementbrief.com/supplements-for-ssri-induced-ed/",
    "https://supplementbrief.com/winter-blues-supplements/"
  ],
  "shelf": {
    "registrySlug": "saffron",
    "label": "Saffron (Crocus sativus) extract",
    "productCount": 250,
    "medianPerServing": 30,
    "p25PerServing": 20,
    "p75PerServing": 89,
    "belowPrimaryFloorPct": 46,
    "abovePrimaryFloorPct": 39,
    "unit": "mg",
    "generatedAt": "2026-09-27T19:07:29.098Z",
    "source": "NIH DSLD bulk CSV (DietarySupplementFacts)"
  },
  "updatedDate": "2026-08-18",
  "dosePageUrl": "https://supplementbrief.com/dose/saffron/",
  "jsonUrl": "https://supplementbrief.com/data/v1/doses/saffron.json",
  "htmlUrl": "https://supplementbrief.com/data/v1/doses/saffron/"
}
